Dasatinib and the Risk of Pulmonary Arterial Hypertension

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
In this podcast, Jennifer Shepherd, a pharmacist in the FDA’s Division of Drug Information, discusses the increased risk of pulmonary arterial hypertension associated with Sprycel (dasatinib), a drug indicated to treat leukemia.

To access the podcast, click here.
Related Articles
New York State Attorney General Eric Schneiderman indicted 3 Brooklyn pharmacies and their employees and owners for allegedly stealing $5 million from the Medicaid program, according to the New York Daily News.
Vince Canzanese, RPh, director of compounding at Burmans Pharmacy in Brookhaven, Pennsylvania, discusses the independent pharmacy’s wellness initiatives.
B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, gives advice to pharmacy students interested in independent pharmacy.
Vince Canzanese, RPh, director of compounding at Burmans Pharmacy, says the independent pharmacy raises awareness about its services by being involved in the Brookhaven, Pennsylvania, community.
Latest Issues
$auto_registration$